Lateral Femoral Cutaneous Nerve Block (LFCN) in ACL Reconstruction With MacFL-type Lateral Tenodesis (RECUP- NCLC)
The goal of this randomized clinical trial is to evaluate whether adding an ultrasound-guided lateral femoral cutaneous nerve (LFCN) block to a standard regional analgesia protocol improves postoperative recovery in patients undergoing anterior cruciate ligament (ACL) reconstruction combined with MacIntosh-type lateral extra-articular tenodesis.
The main question the study aims to answer is whether adding an LFCN block to an adductor canal block (ACB) and an iPACK block improves the quality of postoperative recovery, as measured by the Quality of Recovery-15 (QoR-15) score at 24 hours after surgery.
The study will also assess:
- Preservation of quadriceps function, assessed by the ability to perform a straight leg raise (SLR).
- Postoperative pain at the lateral thigh graft harvest site and knee, at rest and during mobilization.
- Cumulative oral opioid consumption during the first 48 hours after surgery.
- Incidence of postoperative nausea and vomiting (PONV).
- Time to first postoperative ambulation.
- Patient satisfaction with analgesic management.
Adverse events and complications related to regional anesthesia, including sensory disturbances, hematoma, infection, and signs of local anesthetic systemic toxicity.
Participants will be randomly assigned in a 1:1 ratio to one of two treatment groups. All participants will undergo ACL reconstruction combined with MacIntosh-type lateral extra-articular tenodesis and will receive an ACB and an iPACK block. Participants in the experimental group will additionally receive an ultrasound-guided LFCN block.
Postoperative assessments will include QoR-15, pain scores, opioid consumption, PONV, quadriceps function, ambulation, patient satisfaction, and safety assessments during the first 48 hours after surgery and at 1 month. The primary outcome will compare the QoR-15 score at 24 hours between the two groups, with an 8-point difference considered clinically meaningful.
Aperçu de l'étude
Statut
Statut
Les conditions
Les conditions
Intervention / Traitement
Intervention / Traitement
Type d'étude
Type d'étude
Inscription (Estimé)
Inscription
Phase
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
Coordonnées de l'étude
- Nom: Yoann ELMALEH
- Numéro de téléphone: +33 07 81 33 04 31
- E-mail: yoann.d.elmaleh@gmail.com
Lieux d'étude
-
-
-
Quincy-sous-Sénart, France
- Hôpital Privé Claude Galien
-
Contact:
- Yoan Elmaleh
- Numéro de téléphone: +33 7 81 33 04 31
- E-mail: yoann.d.elmaleh@gmail.com
-
Évry, France
- Clinique du Mousseau
-
Contact:
- Karim Guessous
- Numéro de téléphone: +33 6 51 99 54 38
- E-mail: k.guessous@quincyanesthesie.com
-
-
Critères de participation
Critère d'éligibilité
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Adult patients aged 18 to 60 years;
- Presenting a primary anterior cruciate ligament (ACL) tear;
- Scheduled for ACL reconstruction associated with MacIntosh-type lateral extra-articular tenodesis (or equivalent technical variant using an iliotibial band 'ITB' graft);
- Surgery to be performed under general anesthesia;
- Planned management in outpatient surgery or short-stay hospitalization after the operation;
- Understanding the validated French version of the QoR-15 questionnaire;
- Having given their informed consent to participate in the study;
- Patients affiliated with or benefiting from a social security scheme.
Exclusion Criteria:
- Patients having allergy to local anesthetics or a contraindication to peripheral nerve blocks;
- Patients having neuropathy of the lower limbs;
- Patients having coagulation disorders or on major anticoagulation;
- Patients suffering from chronic pain that requires more than 30 mg morphine-equivalents per day;
- Patients undergoing revision ACL reconstruction;
- Patients with pre-existing hypoesthesia of the lateral thigh (e.g. known meralgia paresthetica);
- Patients unable to complete the questionnaires or expressing refusal to participate;
- Pregnant women, women of childbearing age without effective contraception), or women breastfeeding;
- Protected adults under guardianship, curatorship or other legal protection, deprived of liberty or under guardianship or curatorship, or unable to give consent.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Nombre de bras
Armes et Interventions
Groupe de participants / BrasGroupe de participants / Bras |
Intervention / TraitementIntervention / Traitement |
|---|---|
|
Expérimental: ACB + iPACK + LFCN Block
Participants will undergo anterior cruciate ligament reconstruction combined with MacIntosh-type lateral extra-articular tenodesis. They will receive an adductor canal block (ACB) and an iPACK block as the standard regional analgesia protocol, with the addition of an ultrasound-guided lateral femoral cutaneous nerve (LFCN) block. |
Ultrasound-guided adductor canal block administered as part of the standard regional analgesia protocol for ACL reconstruction with MacIntosh-type lateral extra-articular tenodesis. Ultrasound-guided iPACK block (infiltration between the popliteal artery and the posterior capsule of the knee) administered as part of the standard regional analgesia protocol. Ultrasound-guided lateral femoral cutaneous nerve (LFCN) block administered in addition to the adductor canal block and iPACK block in the experimental arm. |
|
Comparateur actif: ACB + iPACK
Participants will undergo anterior cruciate ligament reconstruction combined with MacIntosh-type lateral extra-articular tenodesis. They will receive an adductor canal block (ACB) and an iPACK block without an additional lateral femoral cutaneous nerve (LFCN) block. |
Ultrasound-guided adductor canal block administered as part of the standard regional analgesia protocol for ACL reconstruction with MacIntosh-type lateral extra-articular tenodesis. Ultrasound-guided iPACK block (infiltration between the popliteal artery and the posterior capsule of the knee) administered as part of the standard regional analgesia protocol. |
Que mesure l'étude ?
Principaux critères de jugement
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Quality of Recovery (QoR-15) Score
Délai: 24 hours after surgery
|
The quality of postoperative recovery will be assessed using the Quality of Recovery-15 (QoR-15) questionnaire. The QoR-15 score ranges from 0 to 150, with higher scores indicating better quality of recovery. The score will be assessed preoperatively before administration of regional anesthesia and again 24 hours after surgery. The primary analysis will compare the QoR-15 score at 24 hours between the experimental and active comparator groups. An 8-point difference between groups is considered the minimal clinically important difference. |
24 hours after surgery
|
Mesures de résultats secondaires
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Preservation of Quadriceps Function
Délai: 24 hours after surgery
|
Quadriceps function will be assessed by the ability to perform a straight leg raise (SLR) at 24 hours postoperatively. |
24 hours after surgery
|
|
Postoperative Lateral Thigh and Knee Pain
Délai: 6, 24, and 48 hours after surgery
|
Pain intensity at the lateral thigh graft harvest site and knee will be assessed at rest and during mobilization using the Numeric Rating Scale (NRS), ranging from 0 (no pain) to 10 (worst pain imaginable). |
6, 24, and 48 hours after surgery
|
|
Cumulative Postoperative Opioid Consumption
Délai: Day 0, Day 1, and Day 2 after surgery
|
Total oral opioid consumption will be recorded and converted to morphine milligram equivalents (MME). |
Day 0, Day 1, and Day 2 after surgery
|
|
Postoperative Nausea and Vomiting
Délai: Day 0, Day 1, and Day 2 after surgery
|
The incidence of postoperative nausea and vomiting (PONV) will be recorded during the postoperative period. |
Day 0, Day 1, and Day 2 after surgery
|
|
Time to First Postoperative Ambulation
Délai: Day 1 after surgery
|
Time from surgery to first postoperative ambulation will be recorded in hours. |
Day 1 after surgery
|
|
Patient Satisfaction With Analgesic Management
Délai: Day 1 and Day 2 after surgery
|
Patient satisfaction with postoperative analgesic management will be assessed using a 5-point Likert scale. |
Day 1 and Day 2 after surgery
|
|
Safety and Adverse Events Related to Regional Anesthesia
Délai: Day 1 and 1 month after surgery
|
Adverse events and complications potentially related to regional anesthesia will be recorded, including hypoesthesia or paresthesia of the lateral thigh, abnormal sensory disturbances, hematoma at the LFCN block site, infection, and signs of local anesthetic systemic toxicity. |
Day 1 and 1 month after surgery
|
Collaborateurs et enquêteurs
Parrainer
Parrainer
Les enquêteurs
Les enquêteurs
- Chercheur principal: Yoann ELMALEH, Hôpital Privé Claude Galien
Publications et liens utiles
Publications générales
- Leger M, Campfort M, Cayla C, Parot-Schinkel E, Lasocki S, Rineau E. Validation of an alternative French version of the Quality of Recovery-15 Score: the FQoR-15. Br J Anaesth. 2020 Oct;125(4):e345-e347. doi: 10.1016/j.bja.2020.05.052. Epub 2020 Jul 9. No abstract available.
- Myles PS, Myles DB, Galagher W, Chew C, MacDonald N, Dennis A. Minimal Clinically Important Difference for Three Quality of Recovery Scales. Anesthesiology. 2016 Jul;125(1):39-45. doi: 10.1097/ALN.0000000000001158.
- Demumieux F, Ludes PO, Diemunsch P, Bennett-Guerrero E, Lujic M, Lefebvre F, Noll E. Validation of the translated Quality of Recovery-15 questionnaire in a French-speaking population. Br J Anaesth. 2020 Jun;124(6):761-767. doi: 10.1016/j.bja.2020.03.011. Epub 2020 Apr 15.
- Nakase J, Shimozaki K, Asai K, Yoshimizu R, Kimura M, Tsuchiya H. Usefulness of lateral femoral cutaneous nerve block in combination with femoral nerve block for anterior cruciate ligament reconstruction: a prospective trial. Arch Orthop Trauma Surg. 2021 Mar;141(3):455-460. doi: 10.1007/s00402-020-03724-9. Epub 2021 Jan 2.
- Le Bescond V, Petit-Phan J, Campfort M, Nicolleau C, Conte M, Bouhours G, Rony L, Lasocki S, Leger M. Validation of the postoperative Quality of Recovery-15 questionnaire after emergency surgery and association with quality of life at three months. Can J Anaesth. 2024 May;71(5):590-599. doi: 10.1007/s12630-024-02722-4. Epub 2024 Mar 19.
- Garg DR, Li D, Bordoni B. Anatomy, Bony Pelvis and Lower Limb: Lateral Femoral Cutaneous Nerve. 2026 Feb 15. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK532301/
- Wascher DC, Lording TD, Neyret P. Extra-articular procedures for the ACL-deficient knee: a state of the art review. Journal of ISAKOS. mai 2016;1(3):174-82. doi:10.1136/jisakos-2016-000053
- Uddin I, Chazapis M. Obturator nerve block [Internet]. World Federation of Societies of Anaesthesiologists; juin 2024 [cité 4 févr 2026]. Disponible https://resources.wfsahq.org/atotw/obturator-nerve-block/ doi:10.28923/atotw.525
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Début de l'étude
Achèvement primaire (Estimé)
Achèvement primaire
Achèvement de l'étude (Estimé)
Achèvement de l'étude
Dates d'inscription aux études
Première soumission
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Première publication
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour publiée
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
Autres numéros d'identification d'étude
- COS-RGDS-2025-12-027-P-ELMALEH
- 2026-A01042-49 (Autre identifiant: ID-RCB)
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .